Hoth Therapeutics (HOTH)
(Delayed Data from NSDQ)
$1.16 USD
-0.01 (-0.85%)
Updated Apr 26, 2024 03:58 PM ET
After-Market: $1.18 +0.02 (1.72%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth D Momentum F VGM
Brokerage Reports
0 items in cart
Hoth Therapeutics, Inc. [HOTH]
Reports for Purchase
Showing records 1 - 14 ( 14 total )
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Solving Skin Toxicities of Popular Cancer Drugs; Initiate at Buy and $4 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: PACHAIYAPPAN B
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We are terminating coverage of Hoth Therapeutics, Inc. due to termination of research services.
Provider: Diamond Equity Research LLC
Analyst: Research Department
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Targeting Promising Market with Encouraging Early-Stage Data for Potential Alzheimer''s Disease Therapeutic
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Upcoming Clinical Milestones Supported by Strong Balance Sheet
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Quarterly Results as Expected, With Numerous Upcoming Milestones
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Numerous Positive Recent Developments with Strengthened Balance Sheet to Execute
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Hoth Therapeutics is targeting numerous large addressable markets.-Reinstating Coverage
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
We are terminating coverage due to termination of research services.
Provider: Diamond Equity Research LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Animal Trials Commence to Assess Potential Efficacy of Vaccine HaloVax
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Numerous Positive Developments for HOTH in Challenging Macro Environment
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Increasing Research Efforts with Numerous Early Stage Initiatives
Provider: DIAMOND EQUITY RESEARCH LLC
Analyst: DIAMOND H
Company: Hoth Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
|